128 related articles for article (PubMed ID: 6220548)
1. [Clinical applications of the radioimmunoassay of carcinoembryonic antigen].
Saccani F; Saccani Jotti G; Bagni B
Acta Biomed Ateneo Parmense; 1982; 53(5):361-7. PubMed ID: 6220548
[TBL] [Abstract][Full Text] [Related]
2. [Clinical usefulness of serum TPA, IAP and CEA levels in gynecological cancer].
Saitoh S; Nakanishi A; Noda T; Ando Y; Kamamoto Y; Moriyama I; Ichijo M
Nihon Gan Chiryo Gakkai Shi; 1984 Aug; 19(7):1496-504. PubMed ID: 6520506
[No Abstract] [Full Text] [Related]
3. [A case of immunohistochemically carcinoembryonic antigen producing cervical cancer--the evaluation of plasma CEA levels in 201 patients with uterine cancer].
Yokoyama T; Kaneko H; Kawamura S; Tanaka M; Chiba T; Hiura M; Moriwaki S
Gan No Rinsho; 1987 Jul; 33(8):975-80. PubMed ID: 3613119
[TBL] [Abstract][Full Text] [Related]
4. [Carcino-embryogenic antigen (CEA) in patients with genital tumors (author's transl)].
Anger H; Gleissenberger U
Geburtshilfe Frauenheilkd; 1977 Jul; 37(7):604-8. PubMed ID: 885332
[TBL] [Abstract][Full Text] [Related]
5. Carcinoembryonic antigen in cancer of the female reproductive system: sequential levels and effects of treatment.
Khoo SK; Mackay EV
Aust N Z J Obstet Gynaecol; 1973 Feb; 13(1):1-17. PubMed ID: 4514543
[No Abstract] [Full Text] [Related]
6. [Blood and urinary values of CEA and CA 19-9 in patients with bladder carcinoma].
Cicigoi A; Rocca Rossetti S; Piantino P; Cerchier A
Minerva Med; 1986 Nov; 77(42-43):1983-7. PubMed ID: 3464851
[TBL] [Abstract][Full Text] [Related]
7. [Differential diagnosis of adenocarcinoma of the uterus and cervix using CEA immunohistochemical staining].
Wahlström T; Lindgren J; Korhonen M; Seppälä M
Duodecim; 1980; 96(11):804-7. PubMed ID: 7011782
[No Abstract] [Full Text] [Related]
8. [Clinical significance of tissue polypeptide antigen (TPA) and carbohydrate antigen 12-5 (CA 12-5) in the sera from patients with various gynecologic tumors].
Tohya T; Inoue S; Tanaka N; Fujisaki S; Maeyama M
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2872-5. PubMed ID: 3910744
[No Abstract] [Full Text] [Related]
9. Aspects of the structure and clinical role of the carcinoembryonic antigen (CEA) and related macromolecules with particular reference to urothelial carcinoma.
Neville AM; Nery R; Hall RR; Turberville C; Laurence DJ
Br J Cancer Suppl; 1973 Aug; 1():198-207. PubMed ID: 4216361
[No Abstract] [Full Text] [Related]
10. Immunohistological study of isoantigens, carcinoembryonic antigen and human chorionic gonadotropin in adenocarcinomas of the uterus.
Ueda G; Yamasaki M; Inoue M; Tanaka Y; Hiramatsu K; Inoue Y; Saito J; Nishino T; Kurachi K
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Mar; 36(3):437-42. PubMed ID: 6715926
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical evaluation of nonspecific cross reactive antigen and carcinoembryonic antigen (CEA) in urinary bladder carcinoma.
Asamoto M; Fukushima S; Tatemoto Y; Yamada K; Yuba R; Mori M
Anticancer Res; 1989; 9(2):319-26. PubMed ID: 2751258
[TBL] [Abstract][Full Text] [Related]
12. [Immunohistochemical tissue localization of TA-4 and CEA in uterine carcinomas].
Kimura A; Maruo T; Hoshina M; Mochizuki M
Nihon Gan Chiryo Gakkai Shi; 1987 Jul; 22(6):1159-68. PubMed ID: 3323375
[No Abstract] [Full Text] [Related]
13. Clinical significance of statistical discrimination employing serum TA-4, TPA, and CEA levels in uterine cervical cancer.
Yabushita H; Ogawa A; Masuda T; Noguchi M; Nakanishi M; Ishihara M
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Oct; 38(10):1770-6. PubMed ID: 3782958
[TBL] [Abstract][Full Text] [Related]
14. An immunohistochemical study of difference between cervical and endometrial adenocarcinomas of the uterus--using monoclonal antibodies of CEA and cytokeratin.
Jinnouchi H
Fukushima J Med Sci; 1987 Jun; 33(1):29-46. PubMed ID: 2459040
[No Abstract] [Full Text] [Related]
15. Studies on carcinoembryonic antigen levels in patients with adenocarcinoma of the uterus.
Kjorstad KE; Orjaseter H
Cancer; 1977 Dec; 40(6):2953-6. PubMed ID: 589561
[TBL] [Abstract][Full Text] [Related]
16. [CA 125 (cancer antigen 125), a new tumor associated antigen recognized by monoclonal antibody].
Suzuki H; Teshima K; Noda K
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2719-23. PubMed ID: 6594978
[TBL] [Abstract][Full Text] [Related]
17. [Value of carcinoembryonic antigen (CEA) in the diagnosis of malignant tumors of the urogenital tract].
Rost A; Kneppenberg U; Rost P
Helv Chir Acta; 1976 Jul; 43(3):271-8. PubMed ID: 947865
[TBL] [Abstract][Full Text] [Related]
18. [The behavior of serum concentrations of carcinoembryonic antigens in patients with cervical cancer. 1].
Schrempel A
Zentralbl Gynakol; 1984; 106(18):1248-53. PubMed ID: 6506908
[TBL] [Abstract][Full Text] [Related]
19. Carcinoembryonic antigen in cervical cancer: a five-year follow-up.
Braun P; Leyendecker G
Cancer Detect Prev; 1983; 6(1-2):249-53. PubMed ID: 6883384
[TBL] [Abstract][Full Text] [Related]
20. Tumor-associated antigen(s) from granulosa cell carcinomas of the ovary.
Bhattacharya M; Barlow JJ; Chu TM; Piver MS
Cancer Res; 1974 Apr; 34(4):818-22. PubMed ID: 4205513
[No Abstract] [Full Text] [Related]
[Next] [New Search]
